Ads
related to: benecol smart chews discontinued for sale
Search results
Results From The WOW.Com Content Network
Benecol is a brand of cholesterol -lowering food products owned by the Finnish company Raisio Group, which owns the trademark. Raisio Group licenses the Benecol brand and sells the ingredient stanol ester to food companies around the world. The brand is licensed in more than 30 countries by local food companies such as Kaiku in Spain, Colanta ...
Benecol Buttery Spread. Benecol. Nutrition (Per tbsp): Calories: 70 ... Smart Balance lands a final spot as a healthy butter substitute because the brand loaded its spread with heart-healthy oils ...
Products. Tylenol, Motrin, Imodium, Lactaid, Listerine, Plax, Visine, Benadryl, Caladryl, Zyrtec, Mylanta, Mylicon, Pepcid, Benecol (US license) Parent. Kenvue. McNeil Consumer Healthcare is an American medicals products company belonging to Kenvue consumer health group. It primarily sells fast-moving consumer goods such as over-the-counter drugs.
Benecol Spread False Advertising $2M Class Action Settlement Consumers who purchased certain Benecol spreads may be eligible to claim up to $20 without proof of purchase thanks to a recent settlement.
Vasculitis [3] Alpidem (Ananxyl) 1995. Worldwide. Not approved in the US, withdrawn in France in 1994 [4] and the rest of the market in 1995 because of rare but serious hepatotoxicity. [3][5] Alosetron (Lotronex) 2000. US. Serious gastrointestinal adverse events; ischemic colitis; severe constipation. [2]
The cheesy Enchirito made a brief return in 2022 when fans voted on what discontinued item should come back. A mashup between an enchilada and burrito, the former menu item vanished back in 2013.
Ayds. 1952 ad with Hedy Lamarr. Ayds Reducing Plan Candy (pronounced as "aids") is a discontinued appetite-suppressant candy that enjoyed strong sales in the 1970s and early 1980s and was originally manufactured by The Carlay Company.
(Reuters) -Eli Lilly has sent cease-and-desist letters to U.S. healthcare providers in recent days to stop the promotion of the compounded versions of its drugs for weight loss and diabetes, as ...